A109960 Stock Overview
AP Healthcare Inc. distributes pharmaceutical products in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
AP Healthcare Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩599.00 |
| 52 Week High | ₩2,495.00 |
| 52 Week Low | ₩528.00 |
| Beta | 0.93 |
| 1 Month Change | -5.52% |
| 3 Month Change | -1.64% |
| 1 Year Change | -60.80% |
| 3 Year Change | -83.83% |
| 5 Year Change | -86.15% |
| Change since IPO | -89.11% |
Recent News & Updates
Shareholder Returns
| A109960 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | -2.3% | 1.9% | 2.2% |
| 1Y | -60.8% | 6.5% | 5.4% |
Return vs Industry: A109960 underperformed the KR Biotechs industry which returned 6.5% over the past year.
Return vs Market: A109960 underperformed the KR Market which returned 5.4% over the past year.
Price Volatility
| A109960 volatility | |
|---|---|
| A109960 Average Weekly Movement | 8.6% |
| Biotechs Industry Average Movement | 8.3% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.7% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A109960 has not had significant price volatility in the past 3 months.
Volatility Over Time: A109960's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 16 | Hui Chang | www.aprogen-hng.com |
AP Healthcare Inc. distributes pharmaceutical products in South Korea. It offers prescription and over-the-counter medication, such as antibiotics, antifungal agent, antiviral drugs, infusion solution, peptic ulcer medication, osteoarthritis treatment, purifying solvent, brain function improvement agent, respiratory solvent, topical medicine, adrenocorticosteroids, urinary medicine, hair loss treatment, antipyretic analgesic and anti-inflammatory agent, antihistamines, obesity agents, neural contract, liver extract, fire extinguisher solvent, etc. The company was formerly known as Aprogen Healthcare & Games Inc. and changed its name to AP Healthcare Inc. in April 2024. AP Healthcare Inc. was founded in 1998 and is headquartered in Seongnam-si, South Korea.
AP Healthcare Inc. Fundamentals Summary
| A109960 fundamental statistics | |
|---|---|
| Market cap | ₩68.36b |
| Earnings (TTM) | ₩4.30b |
| Revenue (TTM) | ₩16.01b |
15.9x
P/E Ratio4.3x
P/S RatioIs A109960 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A109960 income statement (TTM) | |
|---|---|
| Revenue | ₩16.01b |
| Cost of Revenue | ₩11.05b |
| Gross Profit | ₩4.96b |
| Other Expenses | ₩656.18m |
| Earnings | ₩4.30b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 37.72 |
| Gross Margin | 30.99% |
| Net Profit Margin | 26.89% |
| Debt/Equity Ratio | 4.7% |
How did A109960 perform over the long term?
See historical performance and comparison